These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

58 related articles for article (PubMed ID: 2562902)

  • 1. Aluminium chelator (transferrin) reverses biochemical deficiency in Alzheimer brain preparations.
    Cowburn JD; Blair JA
    Lancet; 1989 Jan; 1(8629):99. PubMed ID: 2562902
    [No Abstract]   [Full Text] [Related]  

  • 2. Effect of aluminium on in-vitro tetrahydrobiopterin synthesis in brain preparations.
    Cowburn JD; Blair JA
    Lancet; 1987 Jul; 2(8550):105. PubMed ID: 2885559
    [No Abstract]   [Full Text] [Related]  

  • 3. Defective gallium-transferrin binding in Alzheimer disease and Down syndrome: possible mechanism for accumulation of aluminium in brain.
    Farrar G; Altmann P; Welch S; Wychrij O; Ghose B; Lejeune J; Corbett J; Prasher V; Blair JA
    Lancet; 1990 Mar; 335(8692):747-50. PubMed ID: 1969510
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Dialysis dementia, aluminium, and tetrahydrobiopterin metabolism.
    Leeming RJ; Blair JA
    Lancet; 1979 Mar; 1(8115):556. PubMed ID: 85140
    [No Abstract]   [Full Text] [Related]  

  • 5. The effect of tetrahydrofolate on tetrahydrobiopterin metabolism.
    Hamon CG; Blair JA; Barford PA
    J Ment Defic Res; 1986 Jun; 30 ( Pt 2)():179-83. PubMed ID: 3735413
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The silicon link between aluminium and Alzheimer's disease.
    Miu AC
    J Alzheimers Dis; 2006 Sep; 10(1):39-42. PubMed ID: 16988480
    [No Abstract]   [Full Text] [Related]  

  • 7. Tetrahydrobiopterin metabolism in senile dementia of Alzheimer type.
    Aziz AA; Leeming RJ; Blair JA
    J Neurol Neurosurg Psychiatry; 1983 May; 46(5):410-3. PubMed ID: 6152915
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Aluminum as a pathogenic factor in senile dementia of the Alzheimer type: ion specific chelation.
    Kruck TP; McLachlan DR
    Prog Clin Biol Res; 1989; 317():1155-67. PubMed ID: 2690090
    [No Abstract]   [Full Text] [Related]  

  • 9. Gallium-transferrin binding in Alzheimer disease.
    Lancet; 1990 Jun; 335(8701):1348-50. PubMed ID: 1971410
    [No Abstract]   [Full Text] [Related]  

  • 10. Pathogenesis of Alzheimer's disease.
    Hamon CG; Blair JA
    J R Soc Med; 1987 Feb; 80(2):127-9. PubMed ID: 3560144
    [No Abstract]   [Full Text] [Related]  

  • 11. Gallium (aluminium) transferrin binding in Alzheimer's disease.
    Farrar G; Altmann P; Hodgkins P; Blair JA
    Lancet; 1992 Feb; 339(8788):302-3. PubMed ID: 1346299
    [No Abstract]   [Full Text] [Related]  

  • 12. Physiological and clinical chemistry of biopterin.
    Nagatsu T; Matsuura S; Sugimoto T
    Med Res Rev; 1989; 9(1):25-44. PubMed ID: 2644496
    [No Abstract]   [Full Text] [Related]  

  • 13. Transferrin, cholesterol and aluminium in Alzheimer's disease.
    Corrigan FM; Crichton JS; Van Rhijn AG; Skinner ER; Ward NI
    Clin Chim Acta; 1992 Oct; 211(1-2):121-3. PubMed ID: 1468151
    [No Abstract]   [Full Text] [Related]  

  • 14. From coordination chemistry to biological chemistry of aluminium.
    Kiss T
    J Inorg Biochem; 2013 Nov; 128():156-63. PubMed ID: 23870356
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [A new inducible transferrin-independent iron uptake system involved with aluminum accumulation in the brain of patients with Alzheimer's disease].
    Oshiro S
    Tanpakushitsu Kakusan Koso; 1995 Aug; 40(11):1738-43. PubMed ID: 7676035
    [No Abstract]   [Full Text] [Related]  

  • 16. Tetrahydrobiopterin availability in Parkinson's and Alzheimer's disease; potential pathogenic mechanisms.
    Foxton RH; Land JM; Heales SJ
    Neurochem Res; 2007; 32(4-5):751-6. PubMed ID: 17191137
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Transferrin-gallium binding in Alzheimer's disease.
    Lancet; 1991 Nov; 338(8779):1394-6. PubMed ID: 1682757
    [No Abstract]   [Full Text] [Related]  

  • 18. Clioquinol treatment in familiar early onset of Alzheimer's disease: a case report.
    Ibach B; Haen E; Marienhagen J; Hajak G
    Pharmacopsychiatry; 2005 Jul; 38(4):178-9. PubMed ID: 16025421
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Can tetrathiomolybdate be a potential agent against Alzheimer disease? A hypothesis based on abnormal copper homeostasis in brain.
    Sabayan B; Farshchi S; Zamiri N; Sabayan B
    Alzheimer Dis Assoc Disord; 2010; 24(3):309-10. PubMed ID: 20798613
    [No Abstract]   [Full Text] [Related]  

  • 20. Visual evoked potentials and neopterin: biopterin ratios in urine show a high correlation in Alzheimer's disease.
    Hamon CG; Cattell RJ; Wright CE; Wychrij O; Blair JA; Harding GF
    J Neurol Neurosurg Psychiatry; 1988 Feb; 51(2):314-5. PubMed ID: 3346706
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 3.